Links between allergy and cardiovascular or hemostatic system

International Journal of Cardiology

Volumn 170, Issue 3, 2014, Pages 278-285

  Potaczek, Daniel P ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Allergy; Atherosclerosis; Coagulation; FCER1A; Immunoglobulin E; Thrombosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN E; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C;

ALLERGY; ASTHMA; ATHEROSCLEROSIS; ATOPY; DISEASE ASSOCIATION; HEART INFARCTION; HEMOSTASIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; KOUNIS SYNDROME; LIPID BLOOD LEVEL; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE ACTIVATION; VENOUS THROMBOEMBOLISM;

ALLERGY; ATHEROSCLEROSIS; COAGULATION; FCER1A; IMMUNOGLOBULIN E; THROMBOSIS;

ANIMALS; ATHEROSCLEROSIS; BLOOD COAGULATION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; THROMBOSIS;

EID: 84890965863     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.029     Document Type: Review

References (153)

1. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
2. G. Hansson Immune mechanisms in atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 1876 1890
3. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
4. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
5. A. Szczeklik, K. Sladek, A. Szczerba, and J. Dropinski Serum immunoglobulin E response to myocardial infarction Circulation 77 1988 1245 1249
6. M.E. Korkmaz, A. Oto, and Y. Saraçlar et al. Levels of IgE in the serum of patients with coronary arterial disease Int J Cardiol 31 1991 199 204
7. O. Erdogan, C. Gul, A. Altun, and G. Ozbay Increased immunoglobulin E response in acute coronary syndromes Angiology 54 2003 73 79
8. J. Wang, X. Cheng, and M.-X. Xiang et al. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe -/- mice J Clin Invest 121 2011 3564 3577
9. A. Szczeklik, J. Jawień, B.M. Stadler, J. Radwan, W. Piwowarska, and A. Dziatkowiak Possible relationship between interleukin-6 and response of immunoglobulin E to surgical trauma Ann N Y Acad Sci 762 1995 477 479
10. A. Szczeklik, and J. Jawień Immunoglobulin E in acute phase response to surgical stress Clin Exp Allergy 26 1996 303 307
11. O. Erdogan, A. Altun, C. Gul, and G. Ozbay C-reactive protein and immunoglobulin-E response to coronary artery stenting in patients with stable angina Jpn Heart J 44 2003 593 600
12. A. Szczeklik, and J. Jawień Possible role of IgE in acute-phase response Allergy 52 1997 1149 1150
13. J. Marciniak-Sroka, J. Jawień, B. Jakieła, and A. Szczeklik Increase in plasma sCD23 levels precedes immunoglobulin E elevation after coronary artery bypass graft surgery Pol Arch Med Wewn 121 2011 109 114
14. R. Hibbert, P. Teriete, and G. Grundy et al. The structure of human CD23 and its interactions with IgE and CD21 J Exp Med 202 2005 751 760
15. H.J. Gould, and B.J. Sutton IgE in allergy and asthma today Nat Rev Immunol 8 2008 205 217
16. D.P. Potaczek, and M. Kabesch Current concepts of IgE regulation and impact of genetic determinants Clin Exp Allergy 42 2012 852 871
17. N. Kounis Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 110 2006 7 14
18. N.G. Kounis, S.N. Kouni, and C.M. Koutsojannis Myocardial infarction after aspirin treatment, and Kounis syndrome J R Soc Med 98 2005 296
19. N. Kounis, S. Giannopoulos, G. Tsigkas, and J. Goudevenos Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome Int J Cardiol 156 2012 125 132
20. C. Cevik, K. Nugent, G. Shome, and N. Kounis Treatment of Kounis syndrome Int J Cardiol 143 2010 223 226
21. M. Biteker A new classification of Kounis syndrome Int J Cardiol 145 2010 553
22. G. Almpanis, A. Mazarakis, G. Tsigkas, C. Koutsojannis, G.N. Kounis, and N.G. Kounis Acute stent thrombosis and atopy: implications for Kounis syndrome Int J Cardiol 145 2010 398 400
23. N. Kounis Eosinophils and Kounis hypersensitivity associated syndrome as contributors to very late coronary stent thrombosis Int J Cardiol 167 2013 594 595
24. D. González-de-Olano, I. Alvarez-Twose, A. Matito, L. Sánchez-Muñoz, N. Kounis, and L. Escribano Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome? Int J Cardiol 150 2011 210 211
25. M. Triggiani, V. Patella, R. Staiano, F. Granata, and G. Marone Allergy and the cardiovascular system Clin Exp Allergy 153 Suppl. 1 2008 7 11
26. N.G. Kounis, A. Mazarakis, G. Tsigkas, S. Giannopoulos, and J. Goudevenos Kounis syndrome: a new twist on an old disease Future Cardiol 7 2011 805 824
27. B. Takase, T. Maruyama, and A. Kurita et al. Arachidonic acid metabolites in acute myocardial infarction Angiology 47 1996 649 661
28. S. Clejan, S. Japa, and C. Clemetson et al. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis J Cell Mol Med 6 2002 583 592
29. K.J. Filipiak, B. Tarchsalska-Krynska, and G. Opolski et al. Tryptase levels in patients with acute coronary syndromes: the potential new marker in unstable plaque? Clin Cardiol 26 2003 366 372
30. E. Edston, and M. van Hage-Hamsten Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis Int J Cardiol 52 1995 77 81
31. M. Kaartinen, A. Penttilä, and P.T. Kovanen Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture Circulation 90 1994 1669 1678
32. P.T. Kovanen, M. Kaartinen, and T. Paavonen Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 92 1995 1084 1088
33. A. Reid, R. Silver, and R. Levi Renin: at the heart of the mast cell Immunol Rev 217 2007 123 140
34. P. Kovanen Mast cells: multipotent local effector cells in atherothrombosis Immunol Rev 217 2007 105 122
35. A. Nemmar, P.H. Hoet, J. Vermylen, B. Nemery, and M.F. Hoylaerts Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters Circulation 110 2004 1670 1677
36. J. Sun, G.K. Sukhova, and P.J. Wolters et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines Nat Med 13 2007 719 724
37. P. Libby, and G.P. Shi Mast cells as mediators and modulators of atherogenesis Circulation 115 2007 2471 2473
38. C. Weber, A. Zernecke, and P. Libby The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models Nat Rev Immunol 8 2008 802 815
39. G.K. Hansson, P. Libby, U. Schönbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
40. K. Ley, Y. Miller, and C. Hedrick Monocyte and macrophage dynamics during atherogenesis Arterioscler Thromb Vasc Biol 31 2011 1506 1516
41. H. Ma, and P.T. Kovanen IgE-dependent generation of foam cells: an immune mechanism involving degranulation of sensitized mast cells with resultant uptake of LDL by macrophages Arterioscler Thromb Vasc Biol 15 1995 811 819
42. H. Ma, and P.T. Kovanen Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs Arterioscler Thromb Vasc Biol 20 2000 E134 E142
43. C. Binder, and J. Witztum Is atherosclerosis an allergic disease? Circ Res 109 2011 1103 1104
44. R. Tesse, R.C. Pandey, and M. Kabesch Genetic variations in toll-like receptor pathway genes influence asthma and atopy Allergy 66 2011 307 316
45. T. Bieber Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine Allergy 67 2012 1475 1482
46. M.S. Kormann, M. Depner, and D. Hartl et al. Toll-like receptor heterodimer variants protect from childhood asthma J Allergy Clin Immunol 122 2008 86 92
47. D.P. Potaczek, M. Nastalek, K. Okumura, A. Wojas-Pelc, A. Undas, and C. Nishiyama An association of TLR2-16934A>T polymorphism and severity/phenotype of atopic dermatitis J Eur Acad Dermatol Venereol 25 2011 715 721
48. N. Novak, and T. Bieber FcεRI-Toll-like receptor interaction in atopic dermatitis Curr Probl Dermatol 41 2011 47 53
49. R. Saluja, I. Delin, G.P. Nilsson, and M. Adner FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment PLoS One 7 2012 e43547
50. M.H. Criqui, E.R. Lee, R.N. Hamburger, M.R. Klauber, and S.S. Coughlin IgE and cardiovascular disease. Results from a population-based study Am J Med 82 1987 964 968
51. M.H. Criqui Serum immunoglobulin E after myocardial infarction Circulation 78 1988 1322
52. R. Jaramillo, R.D. Cohn, P.W. Crockett, K.M. Gowdy, D.C. Zeldin, and M.B. Fessler Relation between objective measures of atopy and myocardial infarction in the United States J Allergy Clin Immunol 131 2013 405 411
53. E. Benjamin, J. Dupuis, and M. Larson et al. Genome-wide association with select biomarker traits in the Framingham Heart Study BMC Med Genet 8 Suppl. 1 2007 S11
54. U. Ikeda, K. Matsui, Y. Murakami, and K. Shimada Monocyte chemoattractant protein-1 and coronary artery disease Clin Cardiol 25 2002 143 147
55. C. Gonzalez-Quesada, and N.G. Frangogiannis Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes Curr Atheroscler Rep 11 2009 131 138
56. X. Xu, Z. Fang, and B. Wang et al. A genomewide search for quantitative-trait loci underlying asthma Am J Hum Genet 69 2001 1271 1277
57. J. Altmuller, C. Seidel, and Y.A. Lee et al. Phenotypic and genetic heterogeneity in a genome-wide linkage study of asthma families BMC Pulm Med 5 2005 1
58. B.T. Webb, E. van den Oord, and A. Akkari et al. Quantitative linkage genome scan for atopy in a large collection of Caucasian families Hum Genet 121 2007 83 92
59. T. Shikanai, E.S. Silverman, B.W. Morse, C.M. Lilly, H. Inoue, and J.M. Drazen Sequence variants in the FcepsilonRI alpha chain gene J Appl Physiol 93 2002 37 41
60. D.P. Potaczek, M. Sanak, and L. Mastalerz et al. The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels Allergy 61 2006 1230 1233
61. J.S. Bae, S.H. Kim, and Y.M. Ye et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria J Allergy Clin Immunol 119 2007 449 456
62. D.P. Potaczek, M. Sanak, L. Mastalerz, M. Milewski, A. Gawlewicz-Mroczka, and A. Szczeklik Genetic polymorphisms of the novel FCERIA gene region: relation to total serum IgE levels Ann Allergy Asthma Immunol 98 2007 500 501
63. D.P. Potaczek, C. Nishiyama, M. Sanak, A. Szczeklik, and K. Okumura Genetic variability of the high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha) Immunol Res 45 2009 75 84
64. D.P. Potaczek, S. Michel, and V. Sharma et al. Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics Pediatr Allergy Immunol 24 2013 441 449
65. V. Sharma, S. Michel, and V. Gaertner et al. A role of FCER1A and FCER2 polymorphisms in IgE regulation Allergy 2013 10.1111/all.12336
66. S. Weidinger, C. Gieger, and E. Rodriguez et al. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus PLoS Genet 4 2008 e1000166
67. M.F. Moffatt, I.G. Gut, and F. Demenais et al. A large-scale, consortium-based genomewide association study of asthma N Engl J Med 363 2010 1211 1221
68. M. Granada, J.B. Wilk, and M. Tuzova et al. J Allergy Clin Immunol 129 2012 840 845
69. R. Schnabel, J. Baumert, and M. Barbalic et al. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators Blood 115 2010 5289 5299
70. S. Naitza, E. Porcu, and M. Steri et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation PLoS Genet 8 2012 e1002480
71. I. Jialal, S. Devaraj, and S. Venugopal C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44 2004 6 11
72. P. Ridker, G. Pare, and A. Parker et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study Am J Hum Genet 82 2008 1185 1192
73. T. Zeller, P. Wild, and S. Szymczak et al. Genetics and beyond - the transcriptome of human monocytes and disease susceptibility PLoS One 5 2010 e10693
74. M. Inouye, K. Silander, and E. Hamalainen et al. An immune response network associated with blood lipid levels PLoS Genet 6 2010 e1001113
75. M. Inouye, J. Kettunen, and P. Soininen et al. Metabonomic, transcriptomic, and genomic variation of a population cohort Mol Syst Biol 6 2010 441
76. N. Hizawa, E. Yamaguchi, E. Jinushi, and Y. Kawakami A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population Am J Respir Crit Care Med 161 2000 906 909
77. C. Nishiyama, Y. Akizawa, and M. Nishiyama et al. Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy J Immunol 173 2004 6458 6464
78. D.P. Potaczek, M. Sanak, and A. Szczeklik Additive association between FCER1A and FCER1B genetic polymorphisms and total serum IgE levels Allergy 62 2007 1095 1096
79. C. Nishiyama Molecular mechanism of allergy-related gene regulation and hematopoietic cell development by transcription factors Biosci Biotechnol Biochem 70 2006 1 9
80. Y. Baba, K. Maeda, and T. Yashiro et al. GATA2 is a critical transactivator for the human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression J Biol Chem 287 2012 32689 32696
81. M. Hasegawa, C. Nishiyama, and M. Nishiyama et al. A novel - 66T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases J Immunol 171 2003 1927 1933
82. S. Kanada, N. Nakano, and D.P. Potaczek et al. Two different transcription factors discriminate the - 315C>T polymorphism of the Fc epsilon RI alpha gene: binding of Sp1 to - 315C and of a high mobility group-related molecule to - 315T J Immunol 180 2008 8204 8210
83. D.P. Potaczek, K. Maeda, and Q.H. Wang et al. FcepsilonRIalpha gene - 18483A>C polymorphism affects transcriptional activity through YY1 binding Immunogenetics 61 2009 649 655
84. D.P. Potaczek, M. Kamijo, M. Hara, K. Okumura, A. Undas, and C. Nishiyama A comparative search for human FcεRIα gene (FCER1A) 3′-UTR polymorphisms in Japanese and Polish populations Mol Biol Rep 39 2012 3747 3753
85. M. Fessler, M. Massing, and B. Spruell et al. Novel relationship of serum cholesterol with asthma and wheeze in the United States J Allergy Clin Immunol 124 2009 967 974
86. M. Fessler, R. Jaramillo, P. Crockett, and D. Zeldin Relationship of serum cholesterol levels to atopy in the US population Allergy 65 2010 859 864
87. F. Ouyang, R. Kumar, and J. Pongracic et al. Adiposity, serum lipid levels, and allergic sensitization in Chinese men and women J Allergy Clin Immunol 123 2009 940 948
88. T. Schäfer, S. Ruhdorfer, and L. Weigl et al. Intake of unsaturated fatty acids and HDL cholesterol levels are associated with manifestations of atopy in adults Clin Exp Allergy 33 2003 1360 1367
89. T. Kusunoki, T. Morimoto, and M. Sakuma et al. Total and low-density lipoprotein cholesterol levels are associated with atopy in schoolchildren J Pediatr 158 2011 334 336
90. G. Nagel, S. Weiland, K. Rapp, B. Link, I. Zoellner, and W. Koenig Association of apolipoproteins with symptoms of asthma and atopy among schoolchildren Int Arch Allergy Immunol 149 2009 259 266
91. M. Pesonen, A. Ranki, M. Siimes, and M. Kallio Serum cholesterol level in infancy is inversely associated with subsequent allergy in children and adolescents. A 20-year follow-up study Clin Exp Allergy 38 2008 178 184
92. P. Yiallouros, S. Savva, and O. Kolokotroni et al. Low serum high-density lipoprotein cholesterol in childhood is associated with adolescent asthma Clin Exp Allergy 42 2012 423 432
93. H. Otera, T. Ishida, and T. Nishiuma et al. Targeted inactivation of endothelial lipase attenuates lung allergic inflammation through raising plasma HDL level and inhibiting eosinophil infiltration Am J Physiol Lung Cell Mol Physiol 296 2009 L594 L602
94. X. Yao, C. Dai, and K. Fredriksson et al. 5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma J Immunol 186 2011 576 583
95. X. Yao, A.T. Remaley, and S.J. Levine New kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma Chest 140 2011 1048 1054
96. P. Prandoni, F. Bilora, and A. Marchiori et al. An association between atherosclerosis and venous thrombosis N Engl J Med 348 2003 1435 1441
97. G.D. Lowe Is venous thrombosis a risk factor for arterial thrombosis? Lancet 370 2007 1742 1744
98. B. van Aken, P. Reitsma, and F. Rosendaal Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis Br J Haematol 116 2002 173 177
99. P. Reitsma, and F. Rosendaal Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study J Thromb Haemost 2 2004 619 622
100. A. Folsom, P. Lutsey, B. Astor, and M. Cushman C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort Thromb Haemost 102 2009 615 619
101. J. Zacho, A. Tybjaerg-Hansen, and B. Nordestgaard C-reactive protein and risk of venous thromboembolism in the general population Arterioscler Thromb Vasc Biol 30 2010 1672 1678
102. M. Nastałek, A. Wojas-Pelc, and A. Undas Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy J Thromb Thrombolysis 30 2010 121 126
103. A. Undas, K. Zawilska, and M. Ciesla-Dul et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
104. A. Undas, and R. Ariëns Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler Thromb Vasc Biol 31 2011 e88 e99
105. A. Undas, M. Cieśla-Dul, T. Dra̧żkiewicz, D. Potaczek, and J. Sadowski Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less J Thromb Haemost 9 2011 870 873
106. A. Pampuch, K. Kowal, and A. Bodzenta-Lukaszyk et al. The - 675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients Allergy 61 2006 234 238
107. M. Meltzer, T. Lisman, and P. de Groot et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 Blood 116 2010 113 121
108. J. Wojta, C. Kaun, and G. Zorn et al. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils Blood 100 2002 517 523
109. J. Xu, D.S. Postma, and T.D. Howard et al. Major genes regulating total serum immunoglobulin E levels in families with asthma Am J Hum Genet 67 2000 1163 1173
110. S.H. Cho, C.H. Ryu, and C.K. Oh Plasminogen activator inhibitor-1 in the pathogenesis of asthma Exp Biol Med (Maywood) 229 2004 138 146
111. R. Farmer, R. Lawrenson, J. Todd, T. Williams, and K. MacRae Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database Hum Reprod Update 5 1999 688 706
112. C.J. Majoor, P.W. Kamphuisen, and A.H. Zwinderman et al. Risk of deep-vein thrombosis and pulmonary embolism in asthma Eur Respir J 42 2013 655 661
113. C. Huerta, S. Johansson, M.-A. Wallander, and Rodríguez L. García Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom Arch Intern Med 167 2007 935 943
114. M. Cazzola, L. Calzetta, G. Bettoncelli, L. Novelli, C. Cricelli, and P. Rogliani Asthma and comorbid medical illness Eur Respir J 38 2011 42 49
115. J. de Boer, C. Majoor, C. van 't Veer, E. Bel, and T. van der Poll Asthma and coagulation Blood 119 2012 3236 3244
116. L. Bertoletti, S. Quenet, and P. Mismetti et al. Clinical presentation and outcome of venous thromboembolism in COPD Eur Respir J 39 2012 862 868
117. D.P. Potaczek, and A. Undas Allergic burden and the risk of venous thromboembolism Eur Respir J 42 2013 1157 1158
118. C.J. Majoor, and E.H. Bel Allergic burden and the risk of venous thromboembolism Eur Respir J 42 2013 1158 1159
119. A. Kasperska-Zajaç, and B. Rogala Platelet function in anaphylaxis J Investig Allergol Clin Immunol 16 2006 1 4
120. N. Katoh Platelets as versatile regulators of cutaneous inflammation J Dermatol Sci 53 2009 89 95
121. A. Kasperska-Zajac, and B. Rogala Platelet activation during allergic inflammation Inflammation 30 2007 161 166
122. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet function in cutaneous diseases Platelets 19 2008 317 321
123. A. Kasperska-Zajac, M. Nowakowski, and B. Rogala Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome Inflammation 28 2004 299 302
124. R. Tamagawa-Mineoka, N. Katoh, E. Ueda, K. Masuda, and S. Kishimoto Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4 Allergol Int 57 2008 391 396
125. A. Kasperska-Zajac Recovery of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG) plasma concentrations during remission in patients suffering from atopic dermatitis Platelets 21 2010 522 524
126. R. Tamagawa-Mineoka, N. Katoh, E. Ueda, K. Masuda, and S. Kishimoto Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis Clin Immunol 131 2009 495 500
127. M. Nastałek, D. Potaczek, A. Wojas-Pelc, and A. Undas Plasma platelet activation markers in patients with atopic dermatitis and concomitant allergic diseases J Dermatol Sci 64 2011 79 82
128. E. Koczy-Baron, J. Jochem, and A. Kasperska-Zajac Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation Inflamm Res 61 2012 1405 1409
129. O. Watanabe, K. Natori, M. Tamari, Y. Shiomoto, S. Kubo, and Y. Nakamura Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis J Hum Genet 44 1999 173 176
130. R. Tamagawa-Mineoka, N. Katoh, and S. Kishimoto Platelets play important roles in the late phase of the immediate hypersensitivity reaction J Allergy Clin Immunol 123 2009 581 587
131. Y. Zhang, H. Matsuo, and E. Morita Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis Arch Dermatol Res 297 2006 425 429
132. A.P. Oranje, E.J. Glazenburg, A. Wolkerstorfer, and F.B. de Waard-van der Spek Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the tree-item severity score Br J Dermatol 157 2007 645 648
133. H.J. Yang, Y.H. Jeon, and B.Y. Pyun Evaluation of patient's subjective severity using various scoring system in Korean children with atopic dermatitis Asian Pac J Allergy Immunol 28 2010 130 135
134. S. Pitchford, S. Momi, and S. Baglioni et al. Allergen induces the migration of platelets to lung tissue in allergic asthma Am J Respir Crit Care Med 177 2008 604 612
135. S. Pitchford, S. Momi, and S. Giannini et al. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation Blood 105 2005 2074 2081
136. S. Pitchford, Y. Riffo-Vasquez, and A. Sousa et al. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation Blood 103 2004 639 647
137. S. Pitchford, H. Yano, and R. Lever et al. Platelets are essential for leukocyte recruitment in allergic inflammation J Allergy Clin Immunol 112 2003 109 118
138. H. Yamamoto, M. Nagata, and K. Tabe et al. The evidence of platelet activation in bronchial asthma J Allergy Clin Immunol 91 1993 79 87
139. K. Kowal, A. Pampuch, O. Kowal-Bielecka, L. DuBuske, and A. Bodzenta-Łukaszyk Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus Clin Exp Allergy 36 2006 426 432
140. A. Kasperska-Zajac, and B. Rogala Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms Clin Exp Allergy 35 2005 1462 1465
141. A. Kasperska-Zajac, and B. Rogala Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure Inflamm Res 52 2003 477 479
142. S. Danese, S. Vetrano, L. Zhang, V. Poplis, and F. Castellino The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications Blood 115 2010 1121 1130
143. S. Shimizu, T. Shimizu, and J. Morser et al. Role of the coagulation system in allergic inflammation in the upper airways Clin Immunol 129 2008 365 371
144. M. Levi, and T. van der Poll Inflammation and coagulation Crit Care Med 38 2010 S26 S34
145. M. Levi, T. van der Poll, and H. Büller Bidirectional relation between inflammation and coagulation Circulation 109 2004 2698 2704
146. M. Levi, J. Dörffler-Melly, and P. Reitsma et al. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice Blood 101 2003 4823 4827
147. M. Schouten, C. van 't Veer, and J.J. Roelofs et al. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia Thromb Haemost 106 2011 1189 1196
148. H. Yuda, Y. Adachi, and O. Taguchi et al. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice Blood 103 2004 2196 2204
149. J.D. De Boer, C. van 't Veer, and M. Schouten et al. High activated protein C levels attenuate allergic lung inflammation in a murine asthma model using intranasal inoculation of house dust mite extract J Thromb Haemost 9 Suppl. S2 2011 572 [P-WE-167]
150. O. Hataji, O. Taguchi, and E.C. Gabazza et al. Activation of protein C pathway in the airways Lung 180 2002 47 59
151. H. Kanazawa, and T. Yoshikawa Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways Chest 132 2007 1169 1174
152. M. Schouten, M.A. van de Pol, and M. Levi et al. Early activation of coagulation after allergen challenge in patients with allergic asthma J Thromb Haemost 7 2009 1592 1594
153. A. Undas, D.P. Potaczek, C. Nishiyama, and K. Okumura Non-severe allergic asthma is associated with elevated plasma protein C and protein S Thromb Haemost 107 2012 1000 1002